- The Malay Mail Online：Infinitus Welcomes Another SNQ-Accredited Product
- Shares Investment：Infintius CSR Report Honored by GoldenBee for Three Consecutive Years
- Reuters：Infinitus (China) Certified as Top Employer China 2016
- Healthcare Asia Daily：The Chinese Family Business Succession Report Released in Beijing
- Business World Australia：Infinitus Named One of China's Top 10 Companies in Corporate Culture for Four Consecutive Years
- Business World Australia：Infinitus Recognized by China's High-End Platform on Food Safety for 13 Consecutive Years
Shares Investment：Infinitus and Cambridge Jointly Establish International Research CentreRelease Time: 2015-09-18
CAMBRIDGE, England, Sept. 18, 2015 /PRNewswire/ -- On 2 September, the Cambridge Infinitus Research Centre (CIRCE) was officially established by Infinitus (China) Company Ltd. (hereinafter referred to as Infinitus), member of LKK Health Products Group (LKKHPG), and the University of Cambridge. This collaboration marked Infinitus' first academic partnership outside China.
The signing ceremony took place on the Cambridge campus. Mr. Tim Chun, Senior Vice President of LKKHPG, and Sir Leszek Borysiewicz, the Vice-Chancellor of the University of Cambridge, signed the cooperation agreement, and unveiled the plaque along with other representatives from both parties.
The Center is positioned as a world-class research platform which will fully incorporate Cambridge's leading strengths in molecular cell biology with Infinitus' profound accumulation in TCM healthcare after officially put into use. It aims to transform the cutting-edge research findings into innovative TCM health products.
In his speech, Mr. Tim Chun regarded the collaborations with different research institutions as important guarantee of Infinitus' success. "Today, we are gathered here at the University of Cambridge to open a new chapter in Infinitus' science and technology development. To work with the University and to benefit from the profound science and research strength in Cambridge provides Infinitus with great encouragement for the future."
Sir Leszek Borysiewicz said, "Cambridge is well known for its extensive industrial partnerships and we actively encourage a culture of collaboration that strives towards real world impact. These kinds of partnerships are invaluable in helping our academics continue and expand their cutting-edge research. We are delighted that Infinitus have chosen to take their first step in international expansion at Cambridge."
The University of Cambridge reported the ceremony afterwards on its official website, stating that the partnership would expand opportunities for Cambridge academics to collaborate and exchange information with Infinitus' academic collaborators in China, some of whom would visit CIRCE during the course of the partnership.
Founded in 1992, Infinitus focuses on developing, manufacturing and distributing Chinese herbal health products with "Infinitus" as its core brand. Committed to providing high-quality Chinese herbal health products to the public, it has developed 118 products in 5 series that are marketed under 6 brands by far.
It invests hundreds of millions of RMB every year in product research and development, as well as the technical skills improvement. It also closely cooperates with several renowned and authoritative research organizations in the world. Before the collaboration with Cambridge, Infinitus had established five technical platforms in Mainland China and Hong Kong.
LKKHPG is a member of Lee Kum Kee Group, a century-old Hong Kong enterprise. Headquartered in Hong Kong, LKKHPG's businesses cover Chinese herbal plantation, R&D, production, sales and service of TCM health products, mobile internet platform, and real estate investment. Its members include Infinitus (China) Company Ltd., Infinitus (Hong Kong) Company Ltd., Infinitus International Company Ltd., Infinitus International (Malaysia) Sdn Bhd., Naturale (China) Pharma Co., Ltd, and HeHa Digital Health Ltd.
Print Email RSS